{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T08:20:02Z","timestamp":1793262002906,"version":"4.5.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"US Public Health Service","award":["R01HL009610"],"award-info":[{"award-number":["R01HL009610"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1016\/j.bbrc.2013.12.096","type":"journal-article","created":{"date-parts":[[2013,12,25]],"date-time":"2013-12-25T04:15:50Z","timestamp":1387944950000},"page":"1073-1077","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Ezetimibe markedly attenuates hepatic cholesterol accumulation and improves liver function in the lysosomal acid lipase-deficient mouse, a model for cholesteryl ester storage disease"],"prefix":"10.1016","volume":"443","author":[{"given":"Jen-Chieh","family":"Chuang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam M.","family":"Lopez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth S.","family":"Posey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen D.","family":"Turley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2013.12.096_b0005","doi-asserted-by":"crossref","first-page":"3330","DOI":"10.1073\/pnas.76.7.3330","article-title":"Receptor-mediated endocytosis: insights from the lipoprotein receptor system","volume":"76","author":"Brown","year":"1979","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bbrc.2013.12.096_b0010","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1194\/jlr.M700125-JLR200","article-title":"Receptor-mediated and bulk-phase endocytosis cause macrophage and cholesterol accumulation in Niemann-Pick C disease","volume":"48","author":"Liu","year":"2007","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbrc.2013.12.096_b0015","doi-asserted-by":"crossref","first-page":"8487","DOI":"10.1016\/S0021-9258(19)40786-2","article-title":"Role of lysosomal acid lipase in the metabolism of plasma low density lipoprotein. Observations in cultured fibroblasts from a patient with cholesteryl ester storage disease","volume":"250","author":"Goldstein","year":"1975","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2013.12.096_b0020","series-title":"Scriver\u2019s Online Metabolic and Molecular Basis of Inherited Metabolic Disease","article-title":"Lysosomal acid lipase deficiencies: the wolman disease\/cholesteryl ester storage disease spectrum","author":"Grabowski","year":"2012"},{"key":"10.1016\/j.bbrc.2013.12.096_b0025","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1016\/j.jhep.2013.02.014","article-title":"Cholesteryl ester storage disease: review of the findings in 135 reported patients with an underdiagnosed disease","volume":"58","author":"Bernstein","year":"2013","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbrc.2013.12.096_b0030","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1016\/S0022-2275(20)42344-2","article-title":"Lysosomal acid lipase deficiency in rats: lipid analyses and lipase activities in liver and spleen","volume":"31","author":"Kuriyama","year":"1990","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbrc.2013.12.096_b0035","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1093\/hmg\/7.9.1347","article-title":"Targeted disruption of the mouse lysosomal acid lipase gene: long-term survival with massive cholesteryl ester and triglyceride storage","volume":"7","author":"Du","year":"1998","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbrc.2013.12.096_b0040","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S0022-2275(20)31157-3","article-title":"Lysosomal acid lipase-deficient mice: depletion of white and brown fat, severe hepatosplenomegaly, and shortened life span","volume":"42","author":"Du","year":"2001","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbrc.2013.12.096_b0045","doi-asserted-by":"crossref","first-page":"L801","DOI":"10.1152\/ajplung.00335.2003","article-title":"Lysosomal acid lipase deficiency causes respiratory inflammation and destruction in the lung","volume":"286","author":"Lian","year":"2004","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"10.1016\/j.bbrc.2013.12.096_b0050","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1016\/S0022-2275(20)35728-X","article-title":"Role of liver in the maintenance of cholesterol and low density lipoprotein homeostasis in different animal species, including humans","volume":"34","author":"Dietschy","year":"1993","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbrc.2013.12.096_b0055","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1161\/ATVBAHA.113.301637","article-title":"Hepatic remnant lipoprotein clearance by heparan sulfate proteoglycans and low-density lipoprotein receptors depend on dietary conditions in mice","volume":"33","author":"Foley","year":"2013","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbrc.2013.12.096_b0060","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1016\/S0022-2275(20)34932-4","article-title":"Hepatic uptake of chylomicron remnants","volume":"38","author":"Cooper","year":"1997","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbrc.2013.12.096_b0065","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1194\/jlr.M018820","article-title":"Cholesterol esterification by ACAT2 is essential for efficient intestinal cholesterol absorption: evidence from thoracic lymph duct cannulation","volume":"53","author":"Nguyen","year":"2012","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbrc.2013.12.096_b0070","doi-asserted-by":"crossref","first-page":"G813","DOI":"10.1152\/ajpgi.90372.2008","article-title":"Inhibiting intestinal NPC1L1 activity prevents diet-induced increase in biliary cholesterol in Golden Syrian hamsters","volume":"295","author":"Valasek","year":"2008","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.bbrc.2013.12.096_b0075","doi-asserted-by":"crossref","first-page":"G1012","DOI":"10.1152\/ajpgi.00190.2010","article-title":"Multiple mechanisms limit the accumulation of unesterified cholesterol in the small intestine of mice deficient in both ACAT2 and ABCA1","volume":"299","author":"Turley","year":"2010","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.bbrc.2013.12.096_b0080","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1194\/jlr.M027599","article-title":"Blockade of cholesterol absorption by ezetimibe reveals a complex homeostatic network in enterocytes","volume":"53","author":"Engelking","year":"2012","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbrc.2013.12.096_b0085","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.2337\/dc09-1765","article-title":"Effect of ezetimibe on hepatic fat, inflammatory markers, and apolipoprotein B-100 kinetics in insulin-resistant obese subjects on a weight loss diet","volume":"33","author":"Chan","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.bbrc.2013.12.096_b0090","doi-asserted-by":"crossref","first-page":"302847","DOI":"10.1155\/2012\/302847","article-title":"Ezetimibe: its novel effects on the prevention and the treatment of cholesterol gallstones and nonalcoholic fatty liver disease","volume":"2012","author":"de Bari","year":"2012","journal-title":"J. Lipids"},{"key":"10.1016\/j.bbrc.2013.12.096_b0095","doi-asserted-by":"crossref","first-page":"5664","DOI":"10.1016\/j.febslet.2007.11.023","article-title":"Ezetimibe improves liver steatosis and insulin resistance in obese rat model of metabolic syndrome","volume":"581","author":"Deushi","year":"2007","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbrc.2013.12.096_b0100","doi-asserted-by":"crossref","first-page":"G776","DOI":"10.1152\/ajpgi.90275.2008","article-title":"Reduced absorption of saturated fatty acids and resistance to diet-induced obesity and diabetes by ezetimibe-treated and Npc1l1\u2212\/\u2212 mice","volume":"295","author":"Labonte","year":"2008","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.bbrc.2013.12.096_b0105","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.ejphar.2008.01.045","article-title":"Ezetimibe improves high fat and cholesterol diet-induced non-alcoholic fatty liver disease in mice","volume":"584","author":"Zheng","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbrc.2013.12.096_b0110","doi-asserted-by":"crossref","first-page":"3135","DOI":"10.1194\/jlr.M006353","article-title":"Niemann-Pick C1-Like 1 deletion in mice prevents high-fat diet-induced fatty liver by reducing lipogenesis","volume":"51","author":"Jia","year":"2010","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbrc.2013.12.096_b0115","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1111\/j.1872-034X.2011.00888.x","article-title":"Therapeutic effects of ezetimibe for non-alcoholic steatohepatitis in Fatty Liver Shionogi-ob\/ob mice","volume":"41","author":"Matono","year":"2011","journal-title":"Hepatol. Res."},{"key":"10.1016\/j.bbrc.2013.12.096_b0120","doi-asserted-by":"crossref","first-page":"G1043","DOI":"10.1152\/ajpgi.00250.2011","article-title":"Ezetimibe ameliorates intestinal chylomicron overproduction and improves glucose tolerance in a diet-induced hamster model of insulin resistance","volume":"302","author":"Naples","year":"2012","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.bbrc.2013.12.096_b0125","doi-asserted-by":"crossref","first-page":"E293","DOI":"10.1152\/ajpendo.00442.2012","article-title":"Ezetimibe prevents hepatic steatosis induced by a high-fat but not a high-fructose diet","volume":"305","author":"Ushio","year":"2013","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.bbrc.2013.12.096_b0130","article-title":"Novel effect of ezetimibe to inhibit the development of non-alcoholic fatty liver disease in Fatty Liver Shionogi mouse","author":"Wang","year":"2013","journal-title":"Hepatol. Res."},{"key":"10.1016\/j.bbrc.2013.12.096_b0135","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1194\/jlr.M600488-JLR200","article-title":"Lysosomal unesterified cholesterol content correlates with liver cell death in murine Niemann-Pick type C disease","volume":"48","author":"Beltroy","year":"2007","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbrc.2013.12.096_b0140","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1194\/jlr.M013789","article-title":"Quantitative role of LAL, NPC2, and NPC1 in lysosomal cholesterol processing defined by genetic and pharmacological manipulations","volume":"52","author":"Ramirez","year":"2011","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbrc.2013.12.096_b0145","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/0026-0495(82)90206-2","article-title":"Effects of AOMA on cholesterol metabolism in man","volume":"31","author":"Crouse","year":"1982","journal-title":"Metabolism"},{"key":"10.1016\/j.bbrc.2013.12.096_b0150","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1194\/jlr.M400475-JLR200","article-title":"Delineation of molecular changes in intrahepatic cholesterol metabolism resulting from diminished cholesterol absorption","volume":"46","author":"Repa","year":"2005","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbrc.2013.12.096_b0155","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1016\/S0022-2275(20)32171-4","article-title":"Marked reduction in bile acid synthesis in cholesterol 7\u03b1-hydroxylase-deficient mice does not lead to diminished tissue cholesterol turnover or to hypercholesterolemia","volume":"39","author":"Schwarz","year":"1998","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbrc.2013.12.096_b0160","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/S0022-2275(20)41221-0","article-title":"Reevaluation and application of the dual-isotope plasma ratio method for the measurement of intestinal cholesterol absorption in the hamster","volume":"35","author":"Turley","year":"1994","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbrc.2013.12.096_b0165","doi-asserted-by":"crossref","first-page":"289","DOI":"10.2217\/clp.12.31","article-title":"Therapeutic potential of cyclodextrins in the treatment of Niemann-Pick type C disease","volume":"7","author":"Liu","year":"2012","journal-title":"Clin. Lipidol."},{"key":"10.1016\/j.bbrc.2013.12.096_b0170","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1172\/JCI113259","article-title":"Suppression of apolipoprotein B production during treatment of cholesteryl ester storage disease with lovastatin. Implications for regulation of apolipoprotein B synthesis","volume":"80","author":"Ginsberg","year":"1987","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbrc.2013.12.096_b0175","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1194\/jlr.P900004-JLR200","article-title":"Changes in cholesterol absorption and cholesterol synthesis caused by ezetimibe and\/or simvastatin in men","volume":"50","author":"Sudhop","year":"2009","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbrc.2013.12.096_b0180","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1476-511X-4-26","article-title":"Treatment of dyslipidemia with lovastatin and ezetimibe in an adolescent with cholesterol ester storage disease","volume":"4","author":"Tadiboyina","year":"2005","journal-title":"Lipids Health Dis."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X13021670?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X13021670?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,3,20]],"date-time":"2022-03-20T16:08:21Z","timestamp":1647792501000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X13021670"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["S0006291X13021670"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2013.12.096","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ezetimibe markedly attenuates hepatic cholesterol accumulation and improves liver function in the lysosomal acid lipase-deficient mouse, a model for cholesteryl ester storage disease","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2013.12.096","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}